Malaysia Pharmaceuticals and

Healthcare Report Q1 2015

Malaysia Pharmaceuticals and Healthcare

Report Q1 2015
Sector Publishing Intelligence Limited (SPi) has been marketing business and market
research reports from selected publishers for over five years. SPi offers a personal service
to our customers with dedicated research managers who will work with you to source the
best report for your needs. Based in the UK, SPi is well positioned to coordinate our
customers' orders sourced from over 30 global report publishers.
We are pleased to present details of this report to assist your buying decision and
administrative process. You will find easy-to-use How To Buy information on the last page
of this document.
We look forward to being of service to you.
If you have bulk and/or recurring requirements, please get in touch - we can liaise with
publishers to obtain sample pages and negotiate discounts on your behalf.
Phone: +44 (0)1305 753769 or Email: office@sectorpublishing.com

Sector Publishing Intelligence

Limited - 2015

Order at:
http://www.spi-reports.com/product/270612
or email us at office@sectorpublishing.com

Malaysia Pharmaceuticals and Healthcare

Report Q1 2015
BMI View: Malaysia's 2015 budget reinforces our upbeat outlook on the country's pharmaceutical
market. Rising healthcare expenditure plans to improve medical access and efforts to mitigate the
impact of the Goods and Service Tax on medicine prices will provide companies with significant
revenue-earning opportunities. However, downside risks to our outlook include further economic
slowdown forecast for 2015, worries of an increasing number of imitation drugs and growing political
differences within both the opposition and ruling coalitions. Headline Expenditure Projections
Pharmaceuticals: MYR6.60bn (USD2.10bn) in 2013 to MYR7.22bn (USD2.25bn) in 2014; +9.3 % in
local currency and +7.6% in US dollar terms. Forecast revised down from last quarter to better suit
current market conditions.

Additional Details
Publisher : Business Monitor International
Reference : 1748-2038
Number of Pages : 139
Report Format : PDF
Publisher Information :

Business Monitor International (BMI) was founded in 1984 by Richard Londesborough and Jonathan
Feroze, the company's joint CEOs, who both continue to play a full role within the company.
BMI's customers and clients span more than 140 countries worldwide, including more than 400 of the
Global Fortune 500 companies.Businesses, banks, financial service companies, governments,
academia and research centres have all come to rely on BMI's analysis, data and forecasts and have
done so for 25 years. The company was awarded the Queen's Award for Export Achievement in 1997.
BMI is a wholly independent company, headquartered at Blackfriars, London, with foreign offices in
Singapore and New York.
BMI's corporate mission is to become the world's No.1 Independent Information Provider in its field
(Country Risk & Industry Research).

Order at:
http://www.spi-reports.com/product/270612
or email us at office@sectorpublishing.com

Sector Publishing Intelligence

Limited - 2015

Table Of Contents for Malaysia

Pharmaceuticals and Healthcare Report Q1
2015

BMI Industry View . 7

SWOT . 9
Political 11
Economic 13
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Malaysia 2010-2018) . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Healthcare Market Forecast 18
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2010-2018) . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 20102018) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2010-2018) .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Prescription Drug Market Forecast 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Malaysia 2010-2018) . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Patented Drug Market Forecast . 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Malaysia 2010-2018) . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Malaysia 2010-2018) . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
OTC Medicine Market Forecast . 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Malaysia
2010-2018) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Pharmaceutical Trade Forecast . 30
Table: Pharmaceutical Trade Data And Forecasts (Malaysia 2012-2018) . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Malaysia 2012-2018) . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Other Healthcare Data . 34
Key Risks To BMI's Forecast Scenario . 35
Macroeconomic Forecasts . 37
Economic Analysis 37
Risks To Outlook . 39
Table: Economic Activity (Malaysia 2009-2018) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Industry Risk Reward Ratings 41
Asia Pacific Risk/Reward Index 41
Malaysia Risk/Reward Index 47
Rewards 47
Risks . 48
Order at:

Sector Publishing Intelligence

Limited - 2015

http://www.spi-reports.com/product/270612
or email us at office@sectorpublishing.com

Market Overview . 49
Industry Trends And Developments 51
Epidemiology . 51
Healthcare Sector . 55
Table: 2011 Entry Points Projects Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
Healthcare Insurance 58
Table: Main Features Of 1Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
Healthcare Funding . 60
Healthcare Sector Developments . 61
Table: Public Sector And Private Sector Healthcare Developments . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
Medical Tourism . 62
Research & Development 64
Clinical Trials 66
Regulatory Development 68
Regulatory Regime 68
Table: Drug Applications by Type, 2002-2010 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
Table: Registered Pharmaceutical Products by Type, 2002-10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
Regulatory Developments 71
Intellectual Property Issues 75
Pricing Regime . 80
Competitive Landscape 82
Domestic Industry . 82
Foreign Industry . 84
Table: Leading Malaysian Pharmaceutical And Healthcare Companies . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
Culture-Specific Medicines 87
Pharmaceutical Distribution 90
Table: Drug Wholesalers & Importers, 2002-2010 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
Pharmaceutical Retail Sector . 90
Company Profile 93
Bumimedic 93
Kotra Pharma 95
Pfizer . 98
Pharmaniaga . 101
Prime Pharmaceutical 105
Hovid . 107
Chemical Company Of Malaysia 110
GlaxoSmithKline 113
Novartis 116
Merck & Co . 119
Sanofi . 122
Eli Lilly Malaysia . 124
Ranbaxy Malaysia 126
Demographic Forecast . 128
Table:
Order
at: Population Headline Indicators (Malaysia 1990-2025) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

http://www.spi-reports.com/product/270612
or email us at office@sectorpublishing.com

Sector Publishing Intelligence

Limited - 2015

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
Table: Key Population Ratios (Malaysia 1990-2025) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
Table: Urban/Rural Population & Life Expectancy (Malaysia 1990-2025) . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
Table: Population By Age Group (Malaysia 1990-2025) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
Table: Population By Age Group % (Malaysia 1990-2025) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
Glossary . 133
Methodology 135
Pharmaceutical Expenditure Forecast Model 135
Healthcare Expenditure Forecast Model . 135
Notes On Methodology 136
Risk/Reward Index Methodology . 137
Index Overview . 138
Table: Pharmaceutical Risk/Reward Index Indicators . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
Indicator Weightings 139

Sector Publishing Intelligence

Limited - 2015

Order at:
http://www.spi-reports.com/product/270612
or email us at office@sectorpublishing.com

How to Buy...
Malaysia Pharmaceuticals and Healthcare Report Q1 2015

Option 1 - Online
Go to our website and pay online with any major debit or credit card:

http://www.spi-reports.com/product/270612

Option 2 - Request a Proforma Invoice

Fill in the details below, and either Scan this page and email it to us at office@sectorpublishing.com
or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement.

Your Name:
Job Title:
Your Email:
Your Contact Phone:
Company Name:
Address:
Post/Zip Code:
Country:
P.O. Number:
Any Other Instructions:

Price:
$1295 | Price
Payment Options: (please tick one)
Online Credit Card (we will email you the invoice with a payment link)
Direct Wire Transfer (we will email you the invoice with our bank details)

Authorising Signature:

Option 3 - Phone Us on +44 (0)1305 753769

We will be delighted to give you our personal attention.

Order at:
http://www.spi-reports.com/product/270612
or email us at office@sectorpublishing.com

Sector Publishing Intelligence

Limited - 2015